| Browse All

HeartSciences Inc. (HSCSW)

Southlake, United States | NasdaqCM
0.06 USD +0.00 (6.230%) ⇧ (April 17, 2026, 10:56 a.m. EDT)

Short-term: ☆☆☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆
Hot Take | April 19, 2026, 12:42 a.m. EDT

Avoid. HeartSciences shows deteriorating fundamentals with significant negative operating cash flow, negative ROA/ROE, and net debt. Technicals indicate bearish momentum with a 1-minute price drop over the last week, and no dividend support.

None
Attribute Value
Debt to Equity Ratio 145.813
Revenue per Share 0.004
Beta 2.45
Previous Name Heart Test Laboratories, Inc.
Website https://heartsciences.com

Info Dump

Attribute Value
Address1 550 Reserve Street
Address2 Suite 360
Ask 0.0
Ask Size 0
Beta 2.452
Bid 0.0
Bid Size 0
Book Value 0.833
City Southlake
Compensation As Of Epoch Date 1,767,139,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 0.0648
Current Ratio 1.194
Custom Price Alert Confidence HIGH
Day High 0.0648
Day Low 0.0625
Debt To Equity 145.813
Display Name HeartSciences
Ebitda -7,768,315
Ebitda Margins 0.0
Eps Trailing Twelve Months -1.094
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Two Week High 0.0648
Fifty Two Week High Change 0.0
Fifty Two Week High Change Percent 0.0
Fifty Two Week Low 0.0625
Fifty Two Week Low Change 0.0023000017
Fifty Two Week Low Change Percent 0.036800027
Fifty Two Week Range 0.0625 - 0.0648
Financial Currency USD
First Trade Date Milliseconds 1,772,807,400,000
Float Shares 3,070,529
Free Cashflow -4,213,324
Full Exchange Name NasdaqCM
Full Time Employees 15
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.57919
Gross Profits 5,021
Has Pre Post Market Data 1
Industry
Industry Key
Ipo Expected Date 2,022-06-15
Language en-US
Long Business Summary HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-based platform to host AI-ECG algorithms on an ECG hardware agnostic basis. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.
Long Name HeartSciences Inc.
Market us_market
Market State CLOSED
Max Age 86,400
Message Board Id finmb_51732680
Name Change Date 2,026-04-19
Net Income To Common -8,485,301
Open 0.0717
Operating Cashflow -7,340,799
Operating Margins -899.3956
Phone 682 237 7781
Prev Name Heart Test Laboratories, Inc.
Previous Close 0.061
Price Hint 4
Price To Book 0.07779112
Profit Margins 0.0
Quick Ratio 0.796
Quote Source Name Delayed Quote
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change 0.003800001
Regular Market Change Percent 6.22951
Regular Market Day High 0.0648
Regular Market Day Low 0.0625
Regular Market Day Range 0.0625 - 0.0648
Regular Market Open 0.0717
Regular Market Previous Close 0.061
Regular Market Price 0.0648
Regular Market Time 1,776,437,792
Regular Market Volume 799
Return On Assets -0.73509
Return On Equity -3.82323
Revenue Per Share 0.004
Sand P52 Week Change 0.38150132
Sector
Sector Key
Short Name Heart Test Laboratories, Inc. W
Source Interval 15
State TX
Symbol HSCSW
Total Cash 3,397,035
Total Cash Per Share 1.067
Total Debt 3,867,131
Total Revenue 8,669
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -1.094
Trailing Peg Ratio None
Triggerable 1
Type Disp Equity
Volume 799
Website https://heartsciences.com
Zip 76,092